Wolterink G, Van Ree J M
Rudolf Magnus Institute for Pharmacology, Medical Faculty, University of Utrecht, The Netherlands.
Brain Res. 1990 Jan 15;507(1):109-14. doi: 10.1016/0006-8993(90)90528-j.
The functional recovery from impaired motor activity caused by 6-OHDA lesions in the nucleus accumbens is accelerated by the ACTH-related peptides ACTH-(4-10), alpha-MSH (ac-Ser1-ACTH-(1-13)NH2), ACTH-(7-10) and the ACTH-(4-9) analog ORG 2766. The peptides ACTH-(4-7) and Phe-D-Lys-Phe were not effective in this respect. This indicates that this effect of ACTH-derived peptides is located in the 7-10 part of the molecule whereas for the effect of ORG 2766 a bigger part of the molecule may be required. ORG 2766 was effective after intra-accumbal, subcutaneous and oral administration. The differences in potencies between the 3 routes of administration (ED50 0.76 ng/kg, 28.5 ng/kg and 80.6 micrograms/kg, respectively) suggest that the peptide exerts its effect by facilitating recovery processes at the lesion site. Studies with ORG 2766 showed that treatment during the first days following the induction of the lesion is essential for the facilitating action of the peptide on spontaneous recovery from brain damage.
伏隔核中由6-羟基多巴胺损伤引起的运动活动受损后的功能恢复,可被促肾上腺皮质激素相关肽促肾上腺皮质激素-(4-10)、α-促黑素(乙酰化丝氨酸1-促肾上腺皮质激素-(1-13)NH2)、促肾上腺皮质激素-(7-10)以及促肾上腺皮质激素-(4-9)类似物ORG 2766加速。促肾上腺皮质激素-(4-7)和苯丙氨酸-D-赖氨酸-苯丙氨酸在这方面无效。这表明促肾上腺皮质激素衍生肽的这种作用位于分子的7-10部分,而对于ORG 2766的作用,可能需要分子的更大一部分。ORG 2766在伏隔核内、皮下和口服给药后均有效。三种给药途径之间的效力差异(ED50分别为0.76 ng/kg、28.5 ng/kg和80.6 μg/kg)表明,该肽通过促进损伤部位的恢复过程发挥作用。对ORG 2766的研究表明,在损伤诱导后的头几天进行治疗对于该肽促进从脑损伤中自发恢复的作用至关重要。